Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 2Leukemia 2Lymphoma, T-Cell, Cutaneous 1Lymphoma 1Leukemia-Lymphoma, Adult T-Cell 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Hairy Cell 1Hematologic Diseases 1Bronchiolitis Obliterans Syndrome 1

Interventions

Peripheral Blood Stem Cell Transplantation 12Rituximab 9Tacrolimus 8Mycophenolic Acid 8fludarabine phosphate 7Cyclophosphamide 7Whole-Body Irradiation 6Cyclosporine 5Radiotherapy 4Methotrexate 4Granulocyte Colony-Stimulating Factor 4Filgrastim 4Busulfan 4Antilymphocyte Serum 4immunotoxin HA22 3fludarabine 3Etoposide 3Dexamethasone 3Calcium Dobesilate 3plerixafor 2merphos 2Therapeutics 2Sirolimus 2Ondansetron 2Melphalan 2Ipilimumab 2Flow Cytometry 2Diphenhydramine 2Darbepoetin alfa 2Cord Blood Stem Cell Transplantation 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Leukemia, Hairy Cell × B3(Fv)-PE38KDEL recombinant immunotoxin × Clear all
NCT00321555 2023-11-14

LMB-2 to Treat Hairy Cell Leukemia

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
15 enrolled 12 charts
Other hematologic neoplasm

Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡